Catalyst Capital Advisors’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-178
Closed -$7K 594
2018
Q1
$7K Buy
+178
New +$7.48K ﹤0.01% 374

Catalyst Capital Advisors's ARMO Position: Q2 2018 in Review

Catalyst Capital Advisors sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 178 shares — an estimated $7K sold.

Catalyst Capital Advisors first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $7K in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

  • Catalyst Capital Advisors reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Catalyst Capital Advisors sold 178 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $7K.
  • Catalyst Capital Advisors first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • Catalyst Capital Advisors's ARMO BioSciences, Inc. Common Stock position peaked at $7K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Catalyst Capital Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.